The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Immunomedics's Revenue for the
three
months ended in Jun. 2020 was $20.07 Mil. Immunomedics's average Accounts Receivable for the
three
months ended in Jun. 2020 was $22.26 Mil.
Hence, Immunomedics's Receivables Turnover for the
three
months ended in Jun. 2020 was 0.90.
Immunomedics Receivables Turnover Historical Data
The historical data trend for Immunomedics's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Immunomedics's Receivables Turnover
For the Biotechnology subindustry, Immunomedics's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Immunomedics's Receivables Turnover Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Immunomedics's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Immunomedics's Receivables Turnover falls into.
Immunomedics Receivables Turnover Calculation
Receivables Turnover measures the number of times a company collects its average accounts receivable balance.
Immunomedics's Receivables Turnover for the fiscal year that ended in Dec. 2019 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Immunomedics Receivables Turnover Related Terms
Thank you for viewing the detailed overview of Immunomedics's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.
Immunomedics Inc is a clinical-stage biopharmaceutical company, based in the United States. The company develops monoclonal antibody-based products for the targeted treatment of cancer and autoimmune disorders, among others. Its portfolio of products under investigation include antibody-drug conjugates that target the tumor-reducing toxic effects of chemotherapeutic treatments. The company's pipeline includes products targeting solid tumors and hematologic malignancies, among other diseases in clinical and preclinical development. The company is marketing specific diagnostic imaging agents to detect bone infections in Europe, Canada, and Australia. The company has subsidiaries in the Netherlands and Germany to manage sales and clinical trials in Europe.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
IMMU has been successfully added to your 